Filing Details

Accession Number:
0001225208-18-011922
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-24 13:09:31
Reporting Period:
2018-07-20
Accepted Time:
2018-07-24 13:09:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
78003 Pfizer Inc PFE Pharmaceutical Preparations (2834) 135315170
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1263544 Sally Susman Pfizer Inc.-Corp. Secretary
235 East 42Nd St.
New York NY 10017
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-07-20 100 $37.15 155,377 No 4 S Direct
Common Stock Disposition 2018-07-20 300 $37.13 155,077 No 4 S Direct
Common Stock Disposition 2018-07-20 426 $37.14 154,651 No 4 S Direct
Common Stock Disposition 2018-07-20 600 $37.29 154,051 No 4 S Direct
Common Stock Disposition 2018-07-20 700 $37.24 153,351 No 4 S Direct
Common Stock Disposition 2018-07-20 830 $37.30 152,521 No 4 S Direct
Common Stock Disposition 2018-07-20 1,000 $37.27 151,521 No 4 S Direct
Common Stock Disposition 2018-07-20 1,300 $37.28 150,221 No 4 S Direct
Common Stock Disposition 2018-07-20 1,565 $37.18 148,656 No 4 S Direct
Common Stock Disposition 2018-07-20 1,700 $37.23 146,956 No 4 S Direct
Common Stock Disposition 2018-07-20 2,288 $37.19 144,668 No 4 S Direct
Common Stock Disposition 2018-07-20 2,408 $37.16 142,260 No 4 S Direct
Common Stock Disposition 2018-07-20 2,780 $37.26 139,480 No 4 S Direct
Common Stock Disposition 2018-07-20 3,756 $37.17 135,724 No 4 S Direct
Common Stock Disposition 2018-07-20 3,885 $37.21 131,839 No 4 S Direct
Common Stock Disposition 2018-07-20 4,450 $37.20 127,389 No 4 S Direct
Common Stock Disposition 2018-07-20 4,792 $37.22 122,597 No 4 S Direct
Common Stock Disposition 2018-07-20 7,501 $37.25 115,096 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 652 Indirect By Rule 16b-3 Plan
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.